ask="2.29"
ask_size="2800"
average_daily_volume="870790"
bid="2.11"
bid_size="3000"
book_value="0.32"
change="+0.03"
change_from_200_day_moving_average="0.54"
change_from_50_day_moving_average="0.02"
change_from_52_week_high="-0.22"
change_From_52_week_low="1.56"
change_in_percent="+1.36%"
close="2.23"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.17"
ebitda="-24.62M"
eps_estimate_current_year="-0.17"
eps_estimate_next_quarter="-0.04"
eps_estimate_next_year="-0.10"
ex_dividend_date="N/A"
float_shares="113498000"
high="2.26"
high_52_weeks="2.45"
last_trade_date="2/1/2017"
last_trade_price="2.23"
last_trade_size="7063"
last_trade_time="4:00pm"
low="2.15"
low_52_weeks="0.67"
market_capitalization="345.84M"
moving_average_200_day="1.69"
moving_average_50_day="2.21"
name="Antares Pharma
Inc."
notes="N/A"
one_year_target_price="2.67"
open="2.20"
pe_ratio="N/A"
peg_ratio="-0.15"
percent_change_from_200_day_moving_average="+31.70%"
percent_change_from_50_day_moving_average="+1.02%"
percent_change_from_52_week_high="-8.98%"
percent_change_from_52_week_low="+232.84%"
previous_close="2.20"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.96"
price_per_sales="6.85"
revenue="49.83M"
shares_outstanding="155086000"
short_ratio="2.67"
stock_exchange="NCM"
symbol="ATRS"
volume="712720"
weeks_range_52="0.67 - 2.45"
